| ClinicalTrials.gov Identifier: |
NCT01475838 |
| Brief Title: |
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients |
|
|
First Submitted : |
November 17, 2011 |
|
First Submitted that Met QC Criteria : |
November 18, 2011 |
|
First Posted : |
November 21, 2011
(Estimate)
|
|
|
Results First Submitted : |
January 8, 2015 |
|
Results First Submitted that Met QC Criteria : |
January 22, 2015 |
|
Results First Posted : |
January 26, 2015
(Estimate)
|
|
|
Certification/Extension First Submitted : |
August 25, 2014 |
|
Certification/Extension First Submitted that Met QC Criteria : |
August 25, 2014 |
|
Certification/Extension First Posted : |
August 27, 2014
(Estimate)
|
|
|
Last Update Submitted that Met QC Criteria : |
May 6, 2016 |
|
Last Update Posted : |
June 8, 2016
(Estimate)
|
|
